248 related articles for article (PubMed ID: 25264278)
21. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin.
Dong P; Zhang Y; Gu J; Wu W; Li M; Yang J; Zhang L; Lu J; Mu J; Chen L; Li S; Wang J; Liu Y
J Ethnopharmacol; 2011 Oct; 137(3):1373-80. PubMed ID: 21855619
[TBL] [Abstract][Full Text] [Related]
22. Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer.
Ji L; Li H; Gao P; Shang G; Zhang DD; Zhang N; Jiang T
PLoS One; 2013; 8(5):e63404. PubMed ID: 23667609
[TBL] [Abstract][Full Text] [Related]
23. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
[TBL] [Abstract][Full Text] [Related]
24. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells.
Huang ST; Wang CY; Yang RC; Chu CJ; Wu HT; Pang JH
Phytomedicine; 2010 Jan; 17(1):47-54. PubMed ID: 19577445
[TBL] [Abstract][Full Text] [Related]
25. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
[TBL] [Abstract][Full Text] [Related]
26. Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway.
Gao AM; Ke ZP; Shi F; Sun GC; Chen H
Chem Biol Interact; 2013 Oct; 206(1):100-8. PubMed ID: 23994249
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells.
Li Y; Guo Y; Feng Z; Bergan R; Li B; Qin Y; Zhao L; Zhang Z; Shi M
Nutr Cancer; 2019; 71(6):1007-1018. PubMed ID: 31032633
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.
Sampson A; Peterson BG; Tan KW; Iram SH
Biomed Pharmacother; 2019 Oct; 118():109289. PubMed ID: 31401398
[TBL] [Abstract][Full Text] [Related]
29. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX
Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528
[TBL] [Abstract][Full Text] [Related]
30. Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways.
Zhang Z; Cui W; Li G; Yuan S; Xu D; Hoi MP; Lin Z; Dou J; Han Y; Lee SM
J Agric Food Chem; 2012 Aug; 60(33):8171-82. PubMed ID: 22838648
[TBL] [Abstract][Full Text] [Related]
31. [VEGF shRNA enhances the sensitivity of multidrug-resistant leukemia cells to anticancer agent].
Shen HL; Fang LL; Chen C; Fang XJ; Chen QY; Li J; Xu WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):34-9. PubMed ID: 21362217
[TBL] [Abstract][Full Text] [Related]
32. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
33. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
[TBL] [Abstract][Full Text] [Related]
34. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
Wang L; Meng Q; Wang C; Liu Q; Peng J; Huo X; Sun H; Ma X; Liu K
J Nat Prod; 2013 May; 76(5):909-14. PubMed ID: 23621869
[TBL] [Abstract][Full Text] [Related]
35. Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax.
Zhang M; Liu LP; Chen Y; Tian XY; Qin J; Wang D; Li Z; Mo SL
Life Sci; 2013 Jan; 92(1):55-62. PubMed ID: 23142241
[TBL] [Abstract][Full Text] [Related]
36. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells.
Zhang L; Wang Z; Khishignyam T; Chen T; Zhou C; Zhang Z; Jin M; Wang R; Qiu Y; Kong D
Biomed Pharmacother; 2018 Jul; 103():1069-1078. PubMed ID: 29710665
[TBL] [Abstract][Full Text] [Related]
37. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
[TBL] [Abstract][Full Text] [Related]
38. Reversal effect of vitamin D on different multidrug-resistant cells.
Yan M; Nuriding H
Genet Mol Res; 2014 Aug; 13(3):6239-47. PubMed ID: 25158250
[TBL] [Abstract][Full Text] [Related]
39. High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1).
Peterson BG; Tan KW; Osa-Andrews B; Iram SH
Pharmacol Res; 2017 May; 119():313-326. PubMed ID: 28258008
[TBL] [Abstract][Full Text] [Related]
40. Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.
Gao AM; Ke ZP; Wang JN; Yang JY; Chen SY; Chen H
Carcinogenesis; 2013 Aug; 34(8):1806-14. PubMed ID: 23563091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]